Description

Benzoic Acid, 5-Bromo-2-[(1,6-Dihydro-6-Oxo-3-Pyridazinyl)Amino]- is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic-substituted benzoic acid structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific biological pathways. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those with pyridazine-based pharmacophores.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic targets.
• Active Pharmaceutical Ingredient (API) Development: Employed in the research-scale and pilot-scale production of potential APIs for various disease areas.
• Biochemical Research: May be used as a tool compound or a precursor for probes in biochemical and pharmacological assays.
• Fine Chemical Synthesis: Acts as a specialized intermediate for the preparation of complex, high-value organic molecules.

Basic Information

Product Name	Benzoic Acid, 5-Bromo-2-[(1,6-Dihydro-6-Oxo-3-Pyridazinyl)Amino]-
CAS No.	930295-14-0
Molecular Formula	C11H9BrN4O3
Molecular Weight	325.12 g/mol
Synonyms	5-Bromo-2-[(1,6-dihydro-6-oxo-3-pyridazinyl)amino]benzoic acid; 2-Amino-5-bromobenzoic acid pyridazinone derivative; 5-Bromo-2-[(6-oxo-1,6-dihydropyridazin-3-yl)amino]benzoic acid; 3-Amino-6-(5-bromo-2-carboxyphenylamino)pyridazin-2(1H)-one; Benzoic acid, 5-bromo-2-[(1,6-dihydro-6-oxo-3-pyridazinyl)amino]-; 930295-14-0
EINECS	Contact for details

Quality Control

Our Benzoic Acid, 5-Bromo-2-[(1,6-Dihydro-6-Oxo-3-Pyridazinyl)Amino]- is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled accordingly to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.